SCHEMBL3346928

SCHEMBL3346928

Cc1ccc(-c2cnccn2)cc1C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT3 Q9NTG7 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
MKNK1 Q9BUB5 1/20 0.49
MKNK2 Q9HBH9 1/20 0.49
PIM2 Q9P1W9 2/20 0.48
PIM1 P11309 1/20 0.48
HSD11B1 P28845 1/20 0.47
CCNC P24863 1/20 0.44
CDK8 P49336 1/20 0.44
DHODH Q02127 1/20 0.44
HDAC3 O15379 2/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC2 Q92769 2/20 0.43
CHEK1 O14757 1/20 0.42
PIK3CB P42338 2/20 0.42
PIK3CD O00329 1/20 0.42
PIK3CA P42336 1/20 0.42
PI4KA P42356 1/20 0.42
PIK3CG P48736 1/20 0.42
PI4KB Q9UBF8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3342845 0.81 ABL1 (0.45) SIRT3TDP1MKNK1MKNK2PIK3CB
SCHEMBL3346188 0.79 SIRT3 (0.45) SIRT3TDP1MKNK1MKNK2CCNC
SCHEMBL3226601 0.78 MKNK1 (0.78) SIRT3TDP1MKNK1MKNK2
SCHEMBL3342952 0.78 P2RX7 (0.46) SIRT3TDP1MKNK1MKNK2PIK3CB
SCHEMBL2406176 0.77 NPC1 (0.49) PIM2PIM1DHODHCHEK1PIK3CB
SCHEMBL3342234 0.77 KMO (0.47) SIRT3TDP1MKNK1MKNK2PIK3CB
SCHEMBL3346933 0.76 PIK3CD (0.50) TDP1PIM2PIM1HDAC3HDAC1
SCHEMBL3342702 0.76 CHUK (0.68) SIRT3TDP1MKNK1MKNK2CCNC
SCHEMBL10989373 0.75 PIM2 (0.41) PIM2PIM1HSD11B1CCNCCDK8
SCHEMBL3342287 0.75 MKNK2 (0.47) SIRT3TDP1MKNK1MKNK2PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 SIRT3 315/4885TDP1 1578/4885MKNK1 2405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.